Campbell Soup Co. vs Teladoc Health Inc — how do they compare? Campbell Soup Co. trades at $19.21 (market cap $5.78B), while Teladoc Health Inc trades at $5.77 (market cap $1.01B). The key difference: Campbell Soup Co. is far larger — about 5.7× Teladoc Health Inc's market cap, and Campbell Soup Co. pays a 5.16% dividend while Teladoc Health Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Campbell Soup Co. for 98 Days and Teladoc Health Inc for 39 Days on average.
| CPB | TDOC | |
|---|---|---|
Market Cap | $5.78B | $1.01B |
Volume | 11,705,427 | 4,668,477 |
Sector | Consumer Staples | Health |
52-Week High | $31.66 | $9.72 |
52-Week Low | $18.90 | $4.47 |
Typical Hold Time | 98 Days | 39 Days |
Enterprise Value | $12.83B | $1.27B |
Dividend Yield | 5.16% | — |
Signals from Pluang's Aura AI — not financial advice
Campbell's (CPB) trades at $19.37, up 2.49% today, but faces significant headwinds with a recent 36% dividend cut and bearish technical signals. The stock shows mixed earnings performance with two recent beats but a Q4 2026 miss, while fundamentals reveal modest revenue growth to $10.25B but declining net margins to 4.14%. Analyst sentiment remains cautious with only 3.45% buy ratings amid ongoing restructuring efforts.
The outlook remains challenging with weak FY2027 guidance and margin pressure, though current valuation (P/E 14.79) may attract value investors. Key risks include execution of $500M cost savings plan, competitive pressures, and consumer spending trends. The dividend yield near 5% post-cut offers income potential but requires careful monitoring of cash flow sustainability.
TDOC trades at $5.54, down 0.36% on the day, with a bearish technical signal and mixed earnings history. The company reported revenue of $2.53B in 2025 but a net loss of $200.32M, reflecting ongoing profitability challenges. Analyst consensus is a 'Hold' with a $8.83 price target, indicating potential upside. Recent news includes a CFO transition and legal investigations, adding to investor uncertainty.
The outlook remains cautious due to persistent losses and competitive pressures, though valuation metrics like P/S of 0.4 and EV/EBITDA of 5.89 suggest the stock is undervalued. Key risks include weak cash flow trends and BetterHelp segment volatility. Upside depends on execution in integrated care and cost management.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
With a history that dates back around 150 years, Campbell Soup is now a leading manufacturer and marketer of branded convenience food products, most notably soup. The firm's product assortment includes well-known brands like Campbell's, Pace, Prego, Swanson, V8, and Pepperidge Farm. Following the sale of its international snacking operations, which wrapped in calendar 2019, the firm derives nearly all of its sales from its home turf. Campbell has made a handful of acquisitions to reshape its product mix the past few years, including the tie-up with Snyder's-Lance (completed in March 2018), which enhances its exposure to the faster-growing on-trend snack food aisle, complementing its Pepperidge Farm lineup.
Read more on CPB →Teladoc Health is a virtual health provider with a telehealth platform delivering 24-hour, on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. Its platform connects members with a network of physicians and behavioral health professionals. Most of the company's revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has primarily partnered with employers, health plans, and health systems to offer network access to their members.
Read more on TDOC →